Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular events in initially healthy women.
Fast-growing commercial-stage diagnostics company numares AG today announced the worldwide launch of its new, software-based test insightLP™-S50, part of the Company’s lipoFIT® series for lipoprotein ...
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
Find out how lipoprotein(a) screening identifies women at long term cardiovascular risk and supports earlier prevention strategies for heart disease.
NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...
Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested ...
A study finds that a blood test that evaluates levels of three compounds — lipoprotein(a), C-reactive protein (a marker of inflammation), and “bad” LDL cholesterol — can accurately reveal heart ...
Please provide your email address to receive an email when new articles are posted on . Martin, a cardiologist at Johns Hopkins Hospital, professor of medicine at Johns Hopkins University School of ...
Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
Understanding your cholesterol test results in plain English Your doctor hands you a cholesterol report filled with ...
LipoScience, Inc., LPDX a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and ...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results